ACT Biotech Technically exists Dec 2019; Oncology assets acquired by Eddingpharm Jan 2014. ACT Oncology Acquired by Precision for Medicine, Mar 2016, renamed Precision Oncology Acta Vascular Acquired by CardioVasc, Apr 2007 Actagene Oncology Acquired by Ignyta May 2013 Actavalon Shut down Dec 2020 ...
Since January 2015, Amgen and Kite Pharma have strategic partners in the development and commercialize CAR-T cell therapies based on Kite’s engineered autologous cell therapy (eACT™) platform and Amgen’s broad array of cancer targets. The collaboration combines Amgen’s immuno-oncology assets ...
Next week we will turn our focus on catalysts remaining for the quarter, before refreshing our watchlist for the end of the year. Incyte Corporation (NASDAQ: INCY) is a biopharmaceutical company with a strong focus on hematology and oncology, particularly in areas such as myeloproliferative ...
Accel Biotech Acquired by Ximedica, Jul 2016 Acceleron Pharma Acquired by Merck, Nov 2021, $11.5B AccelLAB Acquired by Charles River, Apr 2019 Accelrys Bought by Dassault, 2014 Acceptys Assets acquired by Patrys, Oct 2008 ACCESS Oncology Acquired by Keryx Biopharmaceuticals, Jan 2004 Access Scient...
The International Conference on Carbon Chemistry and Materials is an annual event organized by the United Scientific Group, taking place in the vibrant city of Rome, Italy. This conference is tailored... ConferenceIndustrial Engineering Interested 1 ...
872 oncology pharmaceutical companies 210 $6.14 Find related keywords 873 pharmaceutical mergers and acquisitions 210 $6.13 Find related keywords 874 pharmaceutical companies in los angeles 210 $6.07 Find related keywords 875 pharmaceutical colleges 210 $6.05 Find related keywords 876 cedarburg pharmaceuticals...
Immuno-oncology therapy has been recognized as the epochal breakthrough in oncotherapy, represented by the development and commercialization of PD-1 drugs, it has brought new therapeutic hope to cancer patients worldwide and marked the immuno-oncology therapy era 1.0. But as a broad-spectrum anti...
HYDERABAD, India--(BUSINESS WIRE)--Oct. 25, 2024-- Dr. Reddy’sLaboratories Ltd.(“Dr. Reddy’s”) has been ranked among the top employers according to the 2024Top Biotech and Pharma Employers Surveyconducted byScience. This marks the third consecutive appearance of Dr. Reddy’s in the ...
Amgen has formed several strong partnerships including with AstraZeneca, to work on a drug for colorectal cancer; it has also been investing in artificial intelligence through its partnership with Owkin, particularly in the areas of cardiology, hematology and oncology. It is also regularly ranke...
(Brussels: ABLX.BR) is a biopharmaceutical company engaged in the discovery and development of Nanobodies®, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious and life-threatening human diseases, including inflammation, thrombosis, oncology and...